Game Plan Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

Game Plan Financial Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.47K	Hold	34	–	–	﹤0.01%	255
2026 Q1	$5.74K	Hold	34	–	–	﹤0.01%	230
2025 Q4	$5.74K	Hold	34	–	–	﹤0.01%	234
2025 Q3	$4.91K	Sell	34 -20	-37%	-$2.73K	﹤0.01%	248
2025 Q2	$6.83K	Hold	54	–	–	﹤0.01%	238
2025 Q1	$6.91K	Hold	54	–	–	﹤0.01%	237
2024 Q4	$7.12K	Hold	54	–	–	﹤0.01%	243
2024 Q3	$7.86K	Hold	54	–	–	﹤0.01%	247
2024 Q2	$7.41K	Hold	54	–	–	﹤0.01%	251
2024 Q1	$7.41K	Hold	54	–	–	﹤0.01%	285
2023 Q4	$7.34K	Buy	+54	New	+$6.59K	﹤0.01%	269

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Game Plan Financial Advisors's IBB Position: Q2 2026 in Review

Game Plan Financial Advisors held its iShares Biotechnology ETF (IBB) position steady in Q2 2026 at 34 shares worth $6.47K. The position accounts for ﹤0.01% of the portfolio, ranked #255.

Game Plan Financial Advisors first reported a position in IBB in Q4 2023 and has held it in 11 quarters since. The position peaked at $7.86K in Q3 2024. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Game Plan Financial Advisors held 34 shares of iShares Biotechnology ETF worth $6.47K as of Q2 2026.
Game Plan Financial Advisors left its iShares Biotechnology ETF share count unchanged in Q2 2026.
iShares Biotechnology ETF made up ﹤0.01% of Game Plan Financial Advisors's portfolio in Q2 2026, its #255 holding.
Game Plan Financial Advisors first reported a position in iShares Biotechnology ETF in Q4 2023 and has held it in 11 quarters since.
Game Plan Financial Advisors's iShares Biotechnology ETF position peaked at $7.86K in Q3 2024.
956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Game Plan Financial Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.